Literature DB >> 8546395

Use of plasmid DNA for direct gene transfer and immunization.

H L Davis1, M L Michel, R G Whalen.   

Abstract

Direct gene transfer by intramuscular injection of plasmid DNA encoding an antigenic protein may be used for the purpose of immunization. Several factors influence the uptake and expression of plasmid DNA in skeletal muscle, which in turn influence the immune response to the expressed protein. Physical barriers and other factors may impede the diffusion of the DNA within the muscle tissue or its entry into the muscle fibers. Although the efficiency of gene transfer in normal mouse muscle is low (< 100 fibers per injection site), both humoral and cell-mediated immune responses to the hepatitis B surface antigen (HBsAg) are obtained after the expression of a transferred gene, and these are dose dependent. The efficacy of the immune response can be improved by injection of the DNA in or following pretreatment with a hypertonic solution or with the local anesthetic bupivacaine, and even more so by injecting the DNA into regenerating muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546395     DOI: 10.1111/j.1749-6632.1995.tb44728.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Delivery of recombinant adeno-associated virus vectors to rat diaphragm muscle via direct intramuscular injection.

Authors:  Ashley J Smuder; Darin J Falk; Kurt J Sollanek; W Bradley Nelson; Scott K Powers
Journal:  Hum Gene Ther Methods       Date:  2013-10-11       Impact factor: 2.396

2.  Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.

Authors:  Y Lu; K Q Xin; K Hamajima; T Tsuji; I Aoki; J Yang; S Sasaki; J Fukushima; T Yoshimura; S Toda; E Okada; K Okuda
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 3.  DNA and RNA-based vaccines: principles, progress and prospects.

Authors:  W W Leitner; H Ying; N P Restifo
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

4.  Adjuvant effect of Ubenimex on a DNA vaccine for HIV-1.

Authors:  S Sasaki; J Fukushima; K Hamajima; N Ishii; T Tsuji; K Q Xin; H Mohri; K Okuda
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 5.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

6.  Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.

Authors:  S Sasaki; T Tsuji; K Hamajima; J Fukushima; N Ishii; T Kaneko; K Q Xin; H Mohri; I Aoki; T Okubo; K Nishioka; K Okuda
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response.

Authors:  Gemma Armengol; Lina Maria Ruiz; Sergio Orduz
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

8.  Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus.

Authors:  Jing-Qiang Ren; Wen-Chao Sun; Hui-Jun Lu; Shu-Bo Wen; Jie Jing; Fu-Long Yan; Hao Liu; Cun-Xia Liu; Peng-Peng Xiao; Xing Chen; Shou-Wen Du; Rui Du; Ning-Yi Jin
Journal:  BMC Vet Res       Date:  2014-06-10       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.